Provet Pharma Private Limited, a active private limited company, was established on 14 October 2009 in Chennai, Tamil Nadu, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24231TN2009PTC073198. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Employing 116 professional, Its leadership includes Muthu Selvan Vengan (Managing Director), Suthanthirakumar Senthil (Director). Past directors included Muthu Selvan Vengan, Tapan Saha, Sukakumar Somasundaram. It holds ₹26.03 Cr open charges and ₹24.53 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 9, 1St Floor, 2Nd Lane, Chakrapani Street Narasingapuram Extn., Maduvankarai, Guin, Dy, Chennai, Tamil Nadu, 600032.
U24231TN2009PTC073198
073198
14 October 2009
₹3.00 M
₹2.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Provet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muthu Selvan Vengan | Managing Director | 14 Oct 2009 | Current |
| Suthanthirakumar Senthil | Director | 14 Oct 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Director | 30 Jan 2015 | Past |
| Pramod Abcsdd | Director | 06 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Provet Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.23% increase. The company also saw a substantial improvement in profitability, with a 127.8% increase in profit. The company's net worth Soared by an impressive increase of 90.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Provet Pharma had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹260,285,890.00
₹245,318,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Dec 2021 | Hdfc Bank Limited | ₹26.03 Cr | Open |
| 02 Mar 2022 | Others | ₹2.50 Cr | Satisfied |
| 07 Mar 2017 | Others | ₹16.03 Cr | Satisfied |
| 28 Apr 2010 | Indian Bank | ₹6.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Provet Pharma has a workforce of 116 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Provet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Provet Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 260.29 M registered on 25 Dec 2021 with Charge ID 100521181 was modified on 28 Jul 2025. was completed.
Provet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 02 Mar 2022 via Charge ID 100560773 with Others was fully satisfied on 25 Apr 2024. was completed.
Progress on Provet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity A charge with Others amounted to Rs. 25.00 M with Charge ID 100560773 was registered on 02 Mar 2022. was completed.
The activity A charge registered on 07 Mar 2017 via Charge ID 100107021 with Others was fully satisfied on 09 Feb 2022. was completed.
The CIN of Provet Pharma Private Limited is U24231TN2009PTC073198.
Provet Pharma Private Limited is headquartered at 9, 1St Floor, 2Nd Lane, Chakrapani Street Narasingapuram Extn., Maduvankarai, Guin, Dy, Chennai, Tamil Nadu, 600032.
Provet Pharma Private Limited was incorporated on 14 October 2009.
The current directors of Provet Pharma Private Limited are
The primary industry of Provet Pharma Private Limited is Manufacturing.
Provet Pharma Private Limited is unlisted.
The authorized capital of Provet Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹2.50 M.
The compliance status of Provet Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX